it significantly raises the risk of developing conditions like type 2 diabetes, heart disease, high blood pressure, and even certain types of cancer
These effects are temporary in most cases, but they require proactive management during the adjustment phase
Abbreviations HF: Heart failure T2DM: Type 2 diabetes mellitus SGLT2is: Sodium-glucose cotransporter-2 inhibitors GLP-1RAs: Glucagon-like peptide-1 receptor agonists HR: Hazard ratio References Abdul Basith Khan M, Hashim MJ, King JK, Govender RD, Mustafa H, Al Kaabi J
Scale of projections: Estimates for Wegovy, Mounjaro, and Zepbound are based on Wall Street consensus projections, underscoring investor expectations for explosive growth and demand in the GLP-1 market
Delprat B, Maurice T, Delettre C